To catalogue

Frau Pharma Fenfluramine

Frau Pharma Fenfluramine is developed initially to treat obesity, Fenfluramine is currently undergoing Phase III clinical trials as an anticonvulsant agent to treat refractory generalized tonic-clonic seizures in Dravet syndrome.

Properties

Pharma and Nutraceuticals Functions
  • Anti-Convulsant
  • Supplement

Product families

Applications

Food & Nutrition — Nutrition & Well Being
  • Nutraceuticals & Supplements

Product Families

Pharmaceuticals & Nutraceuticals — Pharmaceutical Actives & Precursors
  • Active Pharmaceutical Ingredients (APIs)

Other characteristics

Functions
Anti-Convulsant, Supplement
Markets
Food & Nutrition
Technology
Pharmaceuticals & Nutraceuticals
Food Ingredients Functions
Supplement

More products by Frau Pharma

The Omnichem website uses cookies. By continuing to use the site, you consent to their use in accordance with our Privacy Policy and to the collection of analytics.